, NOTE: Plasma samples from patients with SLE (n = 5) were used. 1. When viruses are suspected to be present in the biological sample, prepare inactivation buffer by adding 200 µL of a non-ioinic surfactant (0.5% nonidet P40 substitute) to 40 mL Detector/Sample diluent

, Centrifuge biological samples containing the analyte of interest at 10,000 g for 15 min at 4 °C to remove cellular debris

, Mix 185 µL Detector/Sample diluent or inactivation buffer with 100 µL biological sample (final dilution factor 3) and 15 µL anti-IFN-? antibody A (initial concentration 1 mg/mL, final concentration 50 ug/mL) or buffer. Incubate for 30 min at room temperature

, Run samples with and without anti-IFN-? antibody in the single molecule array analyser as described above. NOTE: In case of signal saturation, samples should be further diluted. Also, 300 µL is the volume required for duplicate analysis

A. Isaacs and J. Lindenmann, Classics in Oncology Virus Interference : I. The Interferon, Proc. R. Soc. London. Ser. B, Biol. Sci, vol.147, pp.258-67, 1957.

A. Isaacs, J. Lindenmann, R. C. Valentine, and E. Alerts, Pillars Article: Virus Interference. II. Some Properties of Interferon, Proc. R. Soc. London. Ser. B, Biol. Sci, vol.147, pp.268-73, 1957.

D. Hunt, Thrombotic Microangiopathy Associated with Interferon Beta, N. Engl. J. Med, vol.370, pp.1270-71, 2014.

J. J. Hooks, Immune Interferon in the Circulation of Patients with Autoimmune Disease, N. Engl. J. Med, vol.301, pp.5-8, 1979.

S. A. Greenberg, Interferon-alpha/beta Mediated Innate Immune Mechanisms in Dermatomyositis, Ann. Neurol, vol.57, pp.664-78, 2005.

Y. J. Crow, Type I interferonopathies : a novel set of inborn errors of immunity, Ann. N. Y. Acad. Sci, vol.1238, pp.91-99, 2011.

M. P. Rodero and Y. J. Crow, Type I interferon-mediated monogenic autoinflammation : The type I interferonopathies, a conceptual overview, J. Exp. Med, vol.213, pp.2527-2565, 2016.

J. A. Lewis, A sensitive biological assay for interferons, J. Immunol. Methods, vol.185, pp.9-17, 1995.

A. Meager, Biological assays for interferons, J. Immunol. Methods, vol.261, pp.21-36, 2002.

J. Hua, K. Kirou, C. Lee, and M. K. Crow, Functional Assay of Type I Interferon in Systemic Lupus Erythematosus Plasma and Association With Anti-RNA Binding Protein Autoantibodies, Arthritis Rheumatol, vol.54, pp.1906-1922, 2006.

T. B. Niewold, S. N. Kariuki, G. A. Morgan, S. Shrestha, and L. M. Pachman, Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy, Arthritis Rheumatol, vol.60, pp.1815-1839, 2009.

Y. Seo, G. Kim, H. Kwak, and J. Nam, Validation of a HeLa Mx2 / Luc Reporter Cell Line for the Quantification of Human Type I Interferons, Pharmacology, vol.84, pp.135-144, 2009.

Y. Li, Monocyte surface expression of Fc? receptor RI ( CD64 ), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus, Arthritis Res. Ther, vol.12, pp.1-12, 2010.

M. Berger-rentsch and G. Zimmer, A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of MultiSpecies Type I Interferon, PLoS One, vol.6, p.25858, 2011.

D. M. Rissin, Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations, Nat. Biotechnol, vol.28, pp.595-599, 2010.
DOI : 10.1038/nbt.1641

URL : http://europepmc.org/articles/pmc2919230?pdf=render

D. Wu, M. D. Milutinovic, and D. R. Walt, Single molecule array (Simoa) assay with optimal antibody pairs for cytokine detection in human serum samples, R. Soc. Chem, vol.140, pp.6277-82, 2015.
DOI : 10.1039/c5an01238d

, Scientific Principle of SimoaTM (Single Molecule Array) Technology. Whitepaper 1.0. 1, 2013.

L. Chang, Single molecule enzyme-linked immunosorbent assays: Theoretical considerations, J. Immunol. Methods, vol.378, pp.102-115, 2012.

D. Yeung, Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg / mL levels of cytokines in human serum, J. Immunol. Methods, vol.437, pp.53-63, 2016.

L. Song, Single molecule measurements of tumor necrosis factor ? and interleukin-6 in the plasma of patients with Crohn's disease, J. Immunol. Methods, vol.372, pp.177-186, 2011.

E. G. Meissner, J. Decalf, A. Casrouge, and H. Masur, Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy, PLoS One, vol.10, p.133236, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-01380964

J. Decalf, Inhibition of DPP 4 activity in humans establishes its in vivo role in CXCL 10 post-translational modification: prospective placebo-controlled clinical studies, EMBO Mol. Med, vol.8, pp.679-683, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01380633

E. Rabing-brix-petersen, Rhodopsin in plasma from patients with diabetic retinopathy-development and validation of digital ELISA by Single Molecule Array ( Simoa ) technology, J. Immunol. Methods, vol.446, pp.60-69, 2017.

G. Disanto, Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis, Ann. Neurol, vol.81, pp.857-70, 2017.

L. Song, A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-? 1-42 peptide in human plasma with utility for studies of Alzheimer ' s disease therapeutics, Alzheimers. Res. Ther, vol.8, pp.1-15, 2016.

C. Passaes, Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents, J. Virol, vol.91, pp.2296-2312, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01484315

L. Song, Direct Detection of Bacterial Genomic DNA at Sub-Femtomolar Concentrations Using Single Molecule Arrays, Anal. Chem, vol.85, pp.1932-1941, 2013.

L. Cohen, M. R. Hartman, A. Amardey-wellington, and D. R. Walt, Digital direct detection of microRNAs using single molecule arrays, Nucleic Acids Res, vol.45, p.137, 2017.

S. Meyer, AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies, Cell, vol.166, pp.582-595, 2016.

, Homebrew Assay Development Guide Simoa HD-1 Analyzer & Quanterix SR-X. User-0021 08. Quanterix corporation, 2017.

M. P. Rodero, Detection of interferon alpha protein reveals differential levels and cellular sources in disease, J. Exp. Med, vol.214, pp.1547-1555, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01534181

J. Pleil, M. Angrish, and M. Madden, Immunochemistry for high-throughput screening of human exhaled breath condensate ( EBC ) media : implementation of automated Quanterix SIMOA instrumentation, J. Breath Res, vol.9, p.47108, 2015.

R. Schiess, B. Wollscheid, and R. Aebersold, Targeted Proteomic Strategy for Clinical Biomarker Discovery. Mol. Oncol, vol.3, pp.33-44, 2009.

D. H. Wilson, The Simoa HD-1 Analyzer: A Novel Fully Automated Digital Immunoassay Analyzer with Single-Molecule Sensitivity and Multiplexing, J. Lab. Autom, vol.21, pp.533-547, 2016.

A. J. Rivnak, A fully-automated, six-plex single molecule immunoassay for measuring cytokines in blood, J. Immunol. Methods, vol.424, pp.20-27, 2015.

N. L. Anderson and N. G. Anderson, The Human Plasma Proteome. History, character, and diagnostic prospects, Mol. Cell. proteomics, vol.1, pp.845-867, 2002.

P. J. Tighe, R. R. Ryder, I. Todd, and L. C. Fairclough, ELISA in the multiplex era: Potentials and pitfalls, Proteomics Clin. Appl, vol.9, pp.406-422, 2015.